Home/60 Degrees Pharmaceuticals/Ann M. Miller

AM

Ann M. Miller

Chief Regulatory Affairs Officer

60 Degrees Pharmaceuticals

Therapeutic Areas

Infectious Disease Tropical Disease

60 Degrees Pharmaceuticals Pipeline

Drug	Indication	Phase
ARAKODA® (Tafenoquine)	Malaria Prophylaxis	Approved
Tafenoquine	P. vivax Malaria Radical Cure	Phase 3

Leadership Team at 60 Degrees Pharmaceuticals

Geoffrey S. Dow

Chief Executive Officer & Chairman

View full 60 Degrees Pharmaceuticals profile